COVID-19 患者的缺血性脑卒中、炎症与血管内皮病变。
Ischemic Stroke, Inflammation, and Endotheliopathy in COVID-19 Patients.
机构信息
Department of Neurology (L.S.M., A.S.Z., I.M., P.C., P.L., A.S.J., D.N., J.S., K.N.S., S.S., R.S., L.H.S.), Yale University School of Medicine, New Haven, CT.
Department of Neurosurgery (C.M.), Yale University School of Medicine, New Haven, CT.
出版信息
Stroke. 2021 Jun;52(6):e233-e238. doi: 10.1161/STROKEAHA.120.031971. Epub 2021 May 10.
Abstract
[Figure: see text].
摘要
[图：见正文]。
相似文献
1
Ischemic Stroke, Inflammation, and Endotheliopathy in COVID-19 Patients.COVID-19 患者的缺血性脑卒中、炎症与血管内皮病变。
Stroke. 2021 Jun;52(6):e233-e238. doi: 10.1161/STROKEAHA.120.031971. Epub 2021 May 10.
2
Acute Coronary Syndrome and Ischemic Stroke Discharges in the United States During the COVID-19 Pandemic.新冠疫情期间美国急性冠脉综合征和缺血性卒中的出院情况
Stroke. 2021 Jun;52(6):e239-e241. doi: 10.1161/STROKEAHA.120.033630. Epub 2021 Apr 20.
3
Clinical Characteristics of Inpatients with Coronavirus Disease 2019 and Acute Ischemic Stroke: From Epidemiology to Outcomes.新型冠状病毒肺炎合并急性缺血性脑卒中患者的临床特征：从流行病学到结局。
Curr Neurovasc Res. 2020;17(5):760-764. doi: 10.2174/1567202617999201110200410.
4
Risk factor control after ischemic stroke or transient ischemic attack.缺血性卒中和短暂性脑缺血发作后的危险因素控制。
Acta Neurol Scand. 2021 Apr;143(4):367-374. doi: 10.1111/ane.13398. Epub 2021 Feb 2.
5
Diagnostic and prognostic blood biomarkers in vascular dementia: From the viewpoint of ischemic stroke.血管性痴呆的诊断和预后血液生物标志物：从缺血性卒中的角度来看。
Neurochem Int. 2021 Jun;146:105015. doi: 10.1016/j.neuint.2021.105015. Epub 2021 Mar 26.
6
Risk of ischemic stroke in patients with COVID-19 infection: A systematic review and meta-analysis.COVID-19 感染患者发生缺血性卒中的风险：系统评价和荟萃分析。
Brain Res Bull. 2022 Mar;180:31-37. doi: 10.1016/j.brainresbull.2021.12.011. Epub 2021 Dec 31.
7
Do Elevated Levels of Inflammatory Biomarkers Predict the Risk of Occurrence of Ischemic Stroke in SARS-CoV2 ?: An Observational Study.炎症生物标志物水平升高是否可预测 SARS-CoV2 患者发生缺血性卒中的风险？一项观察性研究。
J Stroke Cerebrovasc Dis. 2021 Nov;30(11):106063. doi: 10.1016/j.jstrokecerebrovasdis.2021.106063. Epub 2021 Aug 20.
8
Moderate Levels of N-Terminal Pro-B-Type Natriuretic Peptide is Associated with Increased Risks of Total and Ischemic Strokes among Japanese: The Circulatory Risk in Communities Study.中等水平的 N 末端 B 型利钠肽前体与日本人群总卒中及缺血性卒中风险增加相关：社区动脉粥样硬化风险研究。
J Atheroscler Thromb. 2020 Aug 1;27(8):751-760. doi: 10.5551/jat.52241. Epub 2020 Jan 11.
9
Predictive value of monocyte to HDL cholesterol ratio for stroke-associated pneumonia in patients with acute ischemic stroke.单核细胞与高密度脂蛋白胆固醇比值对急性缺血性脑卒中患者卒中相关性肺炎的预测价值。
Acta Neurol Belg. 2021 Dec;121(6):1575-1581. doi: 10.1007/s13760-020-01418-y. Epub 2020 Jul 7.
10
Endothelial Function, Inflammation, Thrombosis, and Basal Ganglia Perivascular Spaces in Patients with Stroke.中风患者的内皮功能、炎症、血栓形成与基底节周围血管间隙
J Stroke Cerebrovasc Dis. 2016 Dec;25(12):2925-2931. doi: 10.1016/j.jstrokecerebrovasdis.2016.08.007. Epub 2016 Aug 27.
引用本文的文献
1
Sex Disparities Among Lithuanian Ischemic Stroke Patients According to Laboratory Findings; Comorbidities, Including COVID-19; Acute In-Hospital Complications; and Outcomes.根据实验室检查结果、合并症（包括新冠肺炎）、急性院内并发症及转归分析立陶宛缺血性脑卒中患者的性别差异
Medicina (Kaunas). 2025 Jul 28;61(8):1367. doi: 10.3390/medicina61081367.
2
Neuropsychiatric Manifestations of Long COVID-19: A Narrative Review of Clinical Aspects and Therapeutic Approaches.长新冠的神经精神表现：临床方面与治疗方法的叙述性综述
Life (Basel). 2025 Mar 11;15(3):439. doi: 10.3390/life15030439.
3
The stroke meta-metric, Defect-Free Care, was maintained year-over-year within the Florida stroke registry during the COVID-19 pandemic.在新冠疫情期间，佛罗里达州卒中登记处的卒中元指标“无缺陷护理”年复一年保持稳定。
J Stroke Cerebrovasc Dis. 2025 Feb;34(2):108179. doi: 10.1016/j.jstrokecerebrovasdis.2024.108179. Epub 2024 Dec 6.
4
Neurological, psychological, psychosocial complications of long-COVID and their management.新冠长期症状的神经、心理、社会心理并发症及其管理。
Neurol Sci. 2025 Jan;46(1):1-23. doi: 10.1007/s10072-024-07854-5. Epub 2024 Nov 9.
5
Acute and long-term effects of COVID-19 on brain and mental health: A narrative review.新型冠状病毒肺炎对大脑和心理健康的急性及长期影响：一项叙述性综述
Brain Behav Immun. 2025 Jan;123:928-945. doi: 10.1016/j.bbi.2024.11.007. Epub 2024 Nov 3.
6
Predictive value of admission D-dimer levels in patient with acute ischaemic stroke and COVID-19: a second-wave prospective cohort study.急性缺血性脑卒中合并 COVID-19 患者入院 D-二聚体水平的预测价值：第二波前瞻性队列研究。
BMJ Open. 2024 Apr 5;14(4):e077500. doi: 10.1136/bmjopen-2023-077500.
7
Epidemiology, pathogenesis, and management of Coronavirus disease 2019-associated stroke.2019冠状病毒病相关卒中的流行病学、发病机制及管理
Front Med. 2023 Dec;17(6):1047-1067. doi: 10.1007/s11684-023-1041-7. Epub 2024 Jan 2.
8
Update on Anticoagulation Strategies in Patients with ECMO-A Narrative Review.体外膜肺氧合患者抗凝策略的最新进展：一项叙述性综述
J Clin Med. 2023 Sep 20;12(18):6067. doi: 10.3390/jcm12186067.
9
Lactate Dehydrogenase and Hemorrhagic Stroke During Extracorporeal Membrane Oxygenation for COVID-19.COVID-19 患者体外膜肺氧合治疗期间的乳酸脱氢酶和出血性卒中。
Lung. 2023 Aug;201(4):397-406. doi: 10.1007/s00408-023-00630-w. Epub 2023 Jul 4.
10
Comparison of C-reactive protein with distinct hyperinflammatory biomarkers in association with COVID-19 severity, mortality and SARS-CoV-2 variants.比较 C 反应蛋白与不同的高炎症生物标志物与 COVID-19 严重程度、死亡率和 SARS-CoV-2 变异株的关系。
Front Immunol. 2023 Jun 14;14:1213246. doi: 10.3389/fimmu.2023.1213246. eCollection 2023.
本文引用的文献
1
Atrial Arrhythmias in COVID-19 Patients.新冠病毒感染患者的房性心律失常
JACC Clin Electrophysiol. 2020 Sep;6(9):1189-1190. doi: 10.1016/j.jacep.2020.05.015. Epub 2020 May 28.
2
Systemic Inflammatory Response Syndrome Is a Major Contributor to COVID-19-Associated Coagulopathy: Insights From a Prospective, Single-Center Cohort Study.全身炎症反应综合征是新冠病毒相关凝血病的主要促成因素：一项前瞻性单中心队列研究的见解
Circulation. 2020 Aug 11;142(6):611-614. doi: 10.1161/CIRCULATIONAHA.120.048925. Epub 2020 Jun 17.
3
Acute Cerebrovascular Events in Hospitalized COVID-19 Patients.住院 COVID-19 患者中的急性脑血管事件。
Stroke. 2020 Sep;51(9):e219-e222. doi: 10.1161/STROKEAHA.120.030995. Epub 2020 Jul 20.
4
Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study.新型冠状病毒肺炎相关凝血病中的内皮病变：来自一项单中心横断面研究的证据
Lancet Haematol. 2020 Aug;7(8):e575-e582. doi: 10.1016/S2352-3026(20)30216-7. Epub 2020 Jun 30.
5
Risk of Ischemic Stroke in Patients With Coronavirus Disease 2019 (COVID-19) vs Patients With Influenza.2019冠状病毒病（COVID-19）患者与流感患者发生缺血性卒中的风险比较
JAMA Neurol. 2020 Jul 2;77(11):1-7. doi: 10.1001/jamaneurol.2020.2730.
6
The unique characteristics of COVID-19 coagulopathy.COVID-19 凝血功能障碍的独特特征。
Crit Care. 2020 Jun 18;24(1):360. doi: 10.1186/s13054-020-03077-0.
7
8
Von Willebrand factor as a thrombotic and inflammatory mediator in critical illness.血管性血友病因子作为危重病中的血栓形成和炎症介质。
Transfusion. 2020 Jun;60 Suppl 3(Suppl 3):S158-S166. doi: 10.1111/trf.15667. Epub 2020 Jun 1.
9
Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019: A Review.新型冠状病毒病 2019 时代冠状病毒的神经发病机制和神经表现：综述。
JAMA Neurol. 2020 Aug 1;77(8):1018-1027. doi: 10.1001/jamaneurol.2020.2065.
10
SARS-CoV-2 and Stroke in a New York Healthcare System.SARS-CoV-2 与纽约医疗体系中的中风。
Stroke. 2020 Jul;51(7):2002-2011. doi: 10.1161/STROKEAHA.120.030335. Epub 2020 May 20.
Zotero 插件